﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Shahrekord University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Herbmed Pharmacology</JournalTitle>
      <Issn>2345-5004</Issn>
      <Volume>8</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month>10</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Potentiation of in vitro apoptotic effects of δ-Tocotrienol and Jerantinine A on human lung adenocarcinoma cells</ArticleTitle>
    <FirstPage>333</FirstPage>
    <LastPage>338</LastPage>
    <ELocationID EIdType="doi">10.15171/jhp.2019.49</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ibrahim Babangida</FirstName>
        <LastName>Abubakar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000000293598982</Identifier>
      </Author>
      <Author>
        <FirstName>Hwei-San</FirstName>
        <LastName>Loh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6173-6367</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jhp.2019.49</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2019</Year>
        <Month>04</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2019</Year>
        <Month>06</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: The apoptotic effects of single-compound and combined sub-effective concentrations of δ-tocotrienol and jerantinine A on human lung adenocarcinoma (A549) cells were investigated. Methods: Assays including cell viability, histochemical and immunofluorescence staining techniques, flow cytometry and enzyme activity were used. Results: The combination of δ-tocotrienol with jerantinine A at sub-effective concentrations induced a synergistic effect and improved selective toxicity towards cancerous A549 cells over normal lung fibroblast (MRC5) cells compared to the single-compound jerantinine. Morphological features of apoptosis were evident on treated A549 cells. Combined sub-effective concentrations of δ-tocotrienol with jerantinine A induced a predominantly G2/M cell cycle arrest and characterised by a disruption of microtubular networks mediated via caspase 8, 9 and 3 enzymatic activities. Conclusion: These findings demonstrated improved potency in vitro and reduced dose-related toxicity of jerantinine A to normal cells through prospective combined treatment between low-concentration δ-tocotrienol and jerantinine A for lung cancer.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">δ-Tocotrienol</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Jerantinine A</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Synergism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Apoptosis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Microtubules</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>